NASDAQ · Financial Statements
Moleculin Biotech, Inc. (MBRX) Financial Statements
$0.44
NASDAQ: MBRX
Market Cap $2.36M
Overview Financials Dividend Moleculin Biotech, Inc. most recently reported annual revenue of $0, net profit of $-34.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-23.0M $-31.0M $-30.0M $-27.0M $-25.0M Net Profit $-16.0M $-29.0M $-30.0M $-22.0M $-34.0M EPS $-221.77 $-380.51 $-376.71 $-189.14 $-28.42 Op Margin — — — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $84.0M $57.0M $38.0M $17.0M $22.0M Total Liabilities $5.0M $5.0M $12.0M $11.0M $7.0M Cash $71.0M $43.0M $24.0M $4.0M $9.0M Borrowings $0 $0 $1.0M $0 $0
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-19.0M $-28.0M $-24.0M $-24.0M $-23.0M Investing Cash Flow $0 $0 $0 $0 $0 Financing Cash Flow $0 $0 $0 $0 $0 Net Cash Flow $56.0M $-28.0M $-20.0M $-19.0M $5.0M Free Cash Flow $-19.0M $-28.0M $-24.0M $-24.0M $-23.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA 0.14 FCF Yield -976.12% Quick Ratio 0.94 Interest Coverage -370.18 Return 1Y -85.31% Return 3Y -99.02% Return 5Y -99.81%
Screens featuring this stock